Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,129
datasets available to search
ShareScore release 0.9.0
Dataset results
2,129 results for “Score”
Dataset related to article "Oligoscore: a clinical score to predict overall survival in patients with oligometastatic disease treated with stereotactic body radiotherapy "
<p>This record contains raw data related to article “Oligoscore: a clinical score to predict overall survival in patients with oligometastatic disease treated with stereotactic body radiotherapy"</p> <p>Abstract:</p> <p><strong>Background: </strong> to find clinical features that can predict prognosis in patients with oligometastatic disease treated with stereotactic body radiotherapy (SBRT).</p> <p><strong>Material and methods: </strong> Patients with less than 5 metastases in less than 3 different body sites were included in the analysis. Various clinical and treatment parameters were analyzed to create a Cox proportional hazard model for Overall Survival (OS). Subsequently, significant variables were used to create a score.</p> <p><strong>Results: </strong> 997 patients were analyzed. Median OS was 2.61 years, 1 and 3 years OS was respectively 85% and 43%. Location of the primary tumor, performance status, site of irradiated metastases, presence of extratarget non irradiated lesions and RT dose were significant prognostic factors for OS. These parameters were used to create a score and to distinguish three different classes, with median OS of 5.67 years in low risk, 2.47 years in intermediate risk and 1.82 years in high risk group.</p> <p><strong>Conclusion: </strong> moving from easily accessible clinical parameters, a score was created to help the physician's decision about the better treatment or combination of treatments for the individual patient.</p>
Attentional bias score raw data and R codes
Open the record for dataset details and reuse information.
Bodhgayā, Bihār. Unknown material, the larger fragment scored with a cross mark.
<p>Bodhgayā, Bihār. Unknown material, the larger fragment scored with a cross mark; identified as aquamarine in the nineteenth century. British Museum 1892,1103.61</p> <p> </p>
Dataset related to article "Liver metastases from colorectal cancer: propensity score-based comparison of stereotactic body radiation therapy vs. microwave ablation"
<p>This record contains raw data related to article "Liver metastases from colorectal cancer: propensity score-based comparison of stereotactic body radiation therapy vs. microwave ablation"</p> <p>PURPOSE:</p> <p>The study aim was to compare the disease control in two groups of patients affected by liver metastases from CRC treated with microwave ablation (MWA) or stereotactic body radiation therapy (SBRT).</p> <p>METHODS:</p> <p>We extracted data of patients treated between 2009 and 2016. Inclusion criteria were: (1) maximum diameter of the liver lesions less than 4 cm; (2) no more than three liver lesions; (3) no evidence of progressive or untreated gross disease outside the liver; (4) adequate liver function; (5) no concurrent chemotherapy; (6) minimum age of 18. Tumour response was classified according to EORTC-RECIST criteria. Aim of the present study was to evaluate freedom from local progression (FFLP). To reduce indication bias, an inverse probability of treatment weighting was used to estimate treatment effect.</p> <p>RESULTS:</p> <p>A total of 135 patients with 214 lesions were included in the analysis. Median follow-up time was 24.5 months (range 2.4-95.8). The 1-year freedom from local progression (FFLP) was 88% (95%CI 80-92). In the SBRT group, FFLP was statistically longer than MWA group (p = 0.0214); the 1-year FFLP was 91% (95% CI 81-95) in SBRT group and 84% (95% CI 0.72-0.91) in MWA group. Patients treated with SBRT showed a reduce risk of local relapse compared to MWA (adjusted HR 0.31; 95%CI 0.13-0.70, p = 0.005). As expected, analogous result obtained in the inverse probability weighting analysis (HR 0.38; 95%CI 0.18-0.80; p = 0.011).</p> <p>CONCLUSION:</p> <p>In conclusion, there seems to be an advantage of SBRT compared to MWA in treating CRC liver metastases, particularly for lesions bigger than 30 mm.</p>
Dataset related to article "Hypofractionated radiation therapy (HFRT) versus conventional fractionated radiation therapy (CRT) for newly diagnosed glioblastoma patients. A propensity score matched analysis"
<p>This record contains raw data related to article "Hypofractionated radiation therapy (HFRT) versus conventional fractionated radiation therapy (CRT) for newly diagnosed glioblastoma patients. A propensity score matched analysis"</p> <p>The current treatment for newly diagnosed glioblastoma consists of surgery followed by conventional radiotherapy (CRT) with concomitant and adjuvant chemotherapy. Hypofractionated radiation therapy (HFRT) has been investigated and it resulted feasible and safe. The aim of this study was to evaluate whether HFRT can be comparable to CRT.</p> <p>MATERIALS AND METHODS:</p> <p>The analysis included newly diagnosed glioblastoma patients treated with CRT 60 Gy/30 fractions or HFRT 60 Gy/15 fractions. A propensity score matching analysis (PSM) was performed using a logistic regression that considered age, KPS, extent of surgery, MGMT and IDH status.</p> <p>RESULTS:</p> <p>A total of 267 patients were included; before PSM 169 were in CRT-group and 98 in HRFT-group. After 1:1 matching, 82 patients resulted in each group. The median OS time was 17.9 months for the CRT-group and 16.7 months for the HFRT-group; the 1, 2, 3-year OS rates were 75.6%, 32.7%, and 15.5% for the CRT-group, and 75.6%, 33.3%, and 18.9% for the HFRT-group (p value = 0.8). No statistically significant differences were recorded between the two radiation therapy treatments performed.</p> <p>CONCLUSIONS:</p> <p>A short course of radiation therapy would seem comparable to CRT in terms of outcome and less burdensome for these poor prognosis patients.</p> <p> </p>
ACPAS dataset: Aligned Classical Piano Audio and Score (synthetic subset)
<p><strong>ACPAS</strong> is a dataset with aligned audio and scores for classical piano music containing 497 distinct music scores aligned with 2189 performances, in total 179.77 hours. For each performance, we provide the corresponding performance audio (real recording or synthesized recording), performance MIDI, and MIDI score, together with rhythm and key annotations.</p> <p>This is the <strong>Synthetic subset</strong> of the ACPAS dataset. To download the full dataset and for dataset details, please refer to the dataset webpage at <a href="https://cheriell.github.io/research/ACPAS_dataset">https://cheriell.github.io/research/ACPAS_dataset</a></p> <p>For any questions, suggestions, or comments, please do not hesitate to contact <a href="mailto:lele.liu@qmul.ac.uk">lele.liu@qmul.ac.uk</a></p> <p><strong>How to cite:</strong></p> <p>- Lele Liu, Veronica Morfi, and Emmanouil Benetos, "ACPAS: A Dataset of Aligned Classical Piano Audio and Scores for Audio-to-Score Transcription," in ISMIR Late-breaking Demo, 2021.</p> <p><strong>Funding:</strong></p> <p>L. Liu is a research student at the UKRI Centre for Doctoral Training in Artificial Intelligence and Music, supported jointly by the China Scholarship Council and Queen Mary University of London.</p>
ACPAS dataset: Aligned Classical Piano Audio and Score (real recording subset)
<p><strong>ACPAS</strong> is a dataset with aligned audio and scores for classical piano music containing 497 distinct music scores aligned with 2189 performances, in total 179.77 hours. For each performance, we provide the corresponding performance audio (real recording or synthesized recording), performance MIDI, and MIDI score, together with rhythm and key annotations.</p> <p>This is the <strong>Real recording subset</strong> of the ACPAS dataset. To download the full dataset and for dataset details, please refer to the dataset webpage at <a href="https://cheriell.github.io/research/ACPAS_dataset">https://cheriell.github.io/research/ACPAS_dataset</a></p> <p>For any questions, suggestions, or comments, please do not hesitate to contact <a href="mailto:lele.liu@qmul.ac.uk">lele.liu@qmul.ac.uk</a></p> <p><strong>How to cite:</strong></p> <p>- Lele Liu, Veronica Morfi, and Emmanouil Benetos, "ACPAS: A Dataset of Aligned Classical Piano Audio and Scores for Audio-to-Score Transcription," in ISMIR Late-breaking Demo, 2021.</p> <p><strong>Funding:</strong></p> <p>L. Liu is a research student at the UKRI Centre for Doctoral Training in Artificial Intelligence and Music, supported jointly by the China Scholarship Council and Queen Mary University of London.</p> <p> </p>
Self-Scored Cardiovascular Disease Risk Appraisal
ClinicalTrials.gov study NCT00005529. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Construction and validation of a scoring system for perineural invasion-mediated inflammation in gastric cancer
GEO Series GSE214293. Homo sapiens. 50 samples. Type: Expression profiling by high throughput sequencing.
Transcriptome of accumbens nuclei from mice having low scores of cocaine-dependent conditioned place preference
GEO Series GSE28529. Mus musculus. 5 samples. Type: Expression profiling by array.
Immune infiltration characteristic of colorectal cancer with high and low immune score.
GEO Series GSE271172. Homo sapiens. 45 samples. Type: Expression profiling by high throughput sequencing.
Transcriptomes of subthalamic nuclei, globus pallidus, and accumbens nuclei from mice with low and high scores of cocaine-dependent conditioned place preference
GEO Series GSE28828. Mus musculus. 31 samples. Type: Expression profiling by array.
Transcriptome of globus pallidus from a mouse having a low score of cocaine-dependent conditioned place preference
GEO Series GSE28527. Mus musculus. 4 samples. Type: Expression profiling by array.
Increased HRD score in cisplatin resistant penile cancer cells
GEO Series GSE218782. Homo sapiens. 5 samples. Type: Genome variation profiling by SNP array.
Implication of an Immune Score in Molecular Subtypes and Distant Metastasis of Breast Cancer: Comparison between Western and Chinese Han Patients
GEO Series GSE87377. Homo sapiens. 71 samples. Type: Expression profiling by array.
Dataset related to article "Linac-based stereotactic body radiation therapy vs moderate hypofractionated radiotherapy in prostate cancer: propensity-score based comparison of outcome and toxicity."
<p>OBJECTIVE:</p> <p>Prostate cancer represents the second most common malignancy in the world and majority of patients have diagnosis of localized disease. The aim of the present study was to compare two cohorts of patients treated with moderate hypofractionation (MHRT) or stereotactic body radiation therapy (SBRT).</p> <p>METHODS:</p> <p>We included patients treated between 2010 and 2015. Inclusion criteria were: adenocarcinoma of the prostate; class risks low or intermediate; WHO performance status 0-2. We evaluated rectal, gastrointestinal toxicity and genitourinary. Measures of outcome were biochemical disease-free survival and overall survival. Propensity score was used to approximate the balance in covariates.</p> <p>RESULTS:</p> <p>209 patients were included, treated with MHRT (<em>n</em> = 109) or SBRT (<em>n</em> = 100). Median follow-up time was 37.4 months. Rates of biochemical disease-free survival at 1- and 3 years were 100 and 95%, respectively. There was no significant difference between the two groups (<em>p</em> = 0.868). Rates of overall survival at 1- and 3 years were 100 and 97.1%, respectively with no differences between the two groups (<em>p</em> = 0.312). After propensity scoring matching, no differences were observed in terms of acute and late rectal and gastrointestinal toxicity. While mild genitourinary side-effects were more common in SBRT group (45.5% <em>vs</em> 19.5 %), Grade 2 and 3 toxicity was increased after MHRT (11.7% <em>vs</em> 2.6 %; <em>p</em> = 0.029).</p> <p>CONCLUSIONS:</p> <p>Moderate hypofractionation and SBRT are two effective and safe options for the treatment of low- and intermediate-risk prostate cancer. The analysis showed no difference in terms of disease's control and survival but increased moderate and severe toxicity after MHRT.</p> <p>ADVANCES IN KNOWLEDGE:</p> <p>Moderate hypofractionation and SBRT are comparable in terms of efficacy while moderate and severe toxicity is more common in the first one.</p>
Dataset related to article "Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors "
<p>This record contains raw data related to article "Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors"</p><p>Abstract</p><p><strong>Purpose: </strong>Trabecular bone score (TBS) is a gray-level textural metric that has shown to correlate with risk of fractures in several forms of osteoporosis. The value of TBS in predicting fractures and the effects of bone-active drugs on TBS in aromatase inhibitors (AIs)-induced osteoporosis are still largely unknown. The primary objective of this retrospective study was to assess the effects of denosumab and bisphosphonates (BPs) on TBS and vertebral fractures (VFs) in women exposed to AIs.</p><p><strong>Methods: </strong>241 consecutive women (median age 58 years) with early breast cancer undergoing treatment with AIs were evaluated for TBS, bone mineral density (BMD) and morphometric VFs at baseline and after 18-24 months of follow-up. During the study period, 139 women (57.7%) received denosumab 60 mg every 6 months, 53 (22.0%) BPs, whereas 49 women (20.3%) were not treated with bone-active drugs.</p><p><strong>Results: </strong>Denosumab significantly increased TBS values (from 1.270 to 1.323; P < 0.001) accompanied by a significant decrease in risk of VFs (odds ratio 0.282; P = 0.021). During treatment with BPs, TBS did not significantly change (P = 0.849) and incidence of VFs was not significantly different from women untreated with bone-active drugs (P = 0.427). In the whole population, women with incident VFs showed higher decrease in TBS vs. non-fractured women (P = 0.003), without significant differences in changes of BMD at any skeletal site.</p><p><strong>Conclusions: </strong>TBS variation predicts fracture risk in AIs treated women. Denosumab is effective to induce early increase of TBS and reduction in risk of VFs</p>
Microglial Senescence and Activation in Healthy Aging and Alzheimer's Disease: Systematic Review and Neuropathological Scoring
Open the record for dataset details and reuse information.
Data Set_Urinary Albumin-to-Creatinine Ratio as an Independent Predictor of Long-term Mortality in Atherosclerotic Cardiovascular Disease Patients: A Propensity Score-Matched Study
Open the record for dataset details and reuse information.
CBCL and YSR scores in REDs patients and their parents
<p>This database includes the raw data linked with the paper “Rating behavioral problems in adolescent eating disorders: Parent-child differences” published on “Psychiatry Research”.</p> <p>In this paper, we reported the discrepancies data regarding patients affected by Restrictive Eating Disorders (REDs), specifically we aimed to assess the perception of behavioral problems reported by adolescent patients and their mothers and fathers.</p> <p>REDs patients filled in the self-report questionnaire Youth Self-Report (YSR 11-18) and each parent compiled the Child Behavior Check List (CBCL 6-18). Data were collected at baseline. Dataset does not contain longitudinal data.</p> <p>In this sample, patients self-reported scores were lower in somatic complaints, thought problems and rule-breaking compared to their parents’ ratings.</p> <p>These discrepancies were influenced by patients’ clinical and psychosocial features.</p>
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.